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Stroke is a major public health concern afflicting an estimated 795,000 Americans annually. The associated morbidity
and mortality is staggering. Early treatment with thrombolytics is beneficial. The window for treatment is narrow and
minimization of the time from symptom onset to treatment is vital. The general population is not well informed as to
the warning signs or symptoms of stroke, leading to substantial delays in emergency medical services (EMS) activation.
Ambulance transport of stroke patients to the hospital has demonstrated improvements in key benchmarks such as
door to physician evaluation, door to CT initiation, and increased thrombolytic treatment. Pre-hospital notification
of the impending arrival of a stroke patient allows for vital preparation in the treating emergency department, and
improving timely evaluation and treatment upon arrival of the stroke patient. EMS systems are a vital component of
the management of stroke patients, and resources used to improve these systems are beneficial.
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Background
Stroke is a substantial public health challenge. An
estimated 795,000 people experience stroke annu-
ally, of which 87% are ischemic.1 In 2006, an esti-
mated 6.4 million Americans 20 years old or older
had experienced a stroke within their lifetime.1 The
mortality associated with stroke is devastating, ac-
counting for one in every 18 deaths, making it the
fourth leading killer of Americans and the second
leading cause of death worldwide.2 Of equal con-
cern is that stroke is the leading cause of serious,
long-term adult disability in the United States.3 Fif-
teen to 30% of stroke survivors are left permanently
disabled, while 20% require nursing home care at
three months following their stroke.1 This leads to
direct and indirect healthcare costs estimated at
$73.7 billion in 2010.1 There is an additional loss
of worker productivity and wages, further increas-
ing the cost attributed to stroke. The majority of
costs are due to rehabilitation and nursing home
expenditures.4
Stroke treatment
Currently there is only one approved drug for
the treatment of acute ischemic stroke (AIS)—
intravenous thrombolytic therapy with recombi-
nant tissue-type plasminogen activator (rt-PA). In
1996, the U.S. Food and Drug Administration
(FDA) approved the use of rt-PA for the treatment
of ischemic stroke in patients presenting within
3 hours of symptom onset. This followed publi-
cation of the landmark National Institute of Neuro-
logical Disorders and Stroke (NINDS) rt-PA stroke
study in which 624 patients with AIS were random-
ized to placebo or rt-PA (0.9 mg/kg dose) within
three hours of symptom onset. A 12% absolute im-
provement in favorable outcome with rt-PA treat-
ment, compared with placebo, was demonstrated
(20–38%).5 A similar benefit was realized one year
after stroke as well.6 Patients treated with rt-PA
were at increased risk of developing intracranial
hemorrhage (6.4%) compared with placebo (0.6%);
however, the overall mortality was similar despite
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this risk at three-month and one-year follow-ups.5,6
In 2008, the European Cooperative Acute Stroke
Study (ECASS)-3 trial demonstrated improved clin-
ical outcomes in select patients who were treated
with rt-PA in the 3- to 4.5-h window; however, this
benefit was not as substantial compared with those
treated earlier.7,8 While not yet FDA approved for
this expanded time horizon, rt-PA treatment is rec-
ommended in selected patients up to 4.5 h following
symptom onset by the American Stroke Association
(ASA).8
For acute stroke patients, it is very clear that “time
lost is brain lost.” Thrombolytic therapy can signifi-
cantly improve patient outcome when given as soon
as possible after onset of stroke symptoms.9 NINDS
recommendations published in 1996 outline time
goals for patients being evaluated in the emergency
department (ED) for acute ischemic stroke. These
benchmarks are 10 min for door to ED physician
evaluation, 15 min for door to stroke team or neu-
rologist notification, 25 min for door to computed
tomography (CT) scan initiation, 45 min for door
to expert interpretation of the CT scan, and 60 min
for door to thrombolytic administration.10 Aggres-
sive early management in the emergency depart-
ment can limit the morbidity associated with this
deadly disease process. Despite the clear benefits
of treatment with rt-PA, currently only 2–5% of
patients with ischemic stroke receive thrombolytic
therapy.11 Delayed recognition of stroke symptoms
and delayed arrival to the hospital are major rea-
sons for exclusion from treatment.11,12 Basing our
conclusions on research performed by the Califor-
nia Acute Stroke Pilot Registry Investigators, if pa-
tients with a known time of symptom onset had
immediately called 911, we submit that expected
treatment with thrombolytics within three hours of
symptom onset would have increased from 4.3 to
28.6%.13 The mode of transportation to the hos-
pital is strongly associated with in-hospital delays
in evaluation. Studies have demonstrated that pa-
tients with presumed stroke arriving to the hospital
via EMS were more likely to have brain imaging
performed and interpreted in a timely fashion
than patients arriving by private transportation.11
Therefore, improving the patient’s understanding
of symptoms of stroke with rapid activation of the
EMS system and subsequent rapid transport of the
patient to the hospital can have a substantial impact
on rates of treatment in acute stroke.
Patient activation of EMS
Early patient recognition of signs or symptoms of
stroke and transport via EMS would have the great-
est impact on increasing thrombolytic therapy in
the appropriate patient population.13 In 2005, sur-
veys of patients in 14 states revealed that only 38%
were aware of five warning symptoms of stroke and
would call 911 if they thought someone was having
a stroke. Awareness of these warning signs and the
plan to call 911 were greater in whites versus blacks
and Hispanics, women versus men, and those with
college degrees versus those without a high school
diploma.14 In a study of 163 patients admitted to
an emergency room (ER) with possible stroke, 39%
did not know a single sign or symptom.1 It has been
demonstrated that symptom severity is the single
most important patient-dependent determinant of
net pre-hospital delay.12 Severe stroke presentations
are associated with earlier EMS activation. Because
of the time required in the ER to completely evalu-
ate and assess patients experiencing a stroke before
being able to appropriately treat them with t-PA
(approximately one hour), early EMS activation is
paramount. In addition to potentially increasing
treatment rates, presenting to the hospital as soon as
possible following onset of stroke symptoms would
lead to earlier administration of t-PA, which has
been shown to be more effective.9 Improving pub-
lic education regarding stroke symptoms and the
narrow therapeutic time horizon could have a pro-
found effect on increasing thrombolytic treatment
rates;15,16 however, this type of widespread interven-
tion and public health campaign would likely be very
costly. Because of patients’ lack of understanding of
stroke signs and symptoms, the burden of having a
high index of suspicion for stroke is transferred to
EMS personnel and dispatchers.17
EMS dispatch
Timely and appropriate care from EMS can play a
major role in reducing the time from stroke onset to
thrombolytic treatment. Data indicate that between
29 and 65% of patients with signs or symptoms of
stroke contact the health system via EMS.11,18 EMS
dispatchers are the first link in the chain leading to
hospital presentation for many stroke patients. It is
imperative that dispatchers are well trained to detect
stroke symptoms from the initial call in addition to
appropriate triage and prioritized dispatch of emer-
gency medical personnel to the location.18 Training
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programs for EMS dispatchers have shown that dis-
patch accuracy for stroke can be improved.19,20
EMS assessment
The time-sensitive nature of the treatment of acute
ischemic stroke has important implications for
paramedics. They must be proficient in their abil-
ity to recognize, assess, manage, treat, and transport
stroke patients.17 Once the ambulance arrives on
the scene, the EMS provider should obtain key his-
torical details. Accurate identification of the time of
symptom onset is paramount. EMS providers may
have the best chance of obtaining the most accurate
history because of access to family, caregivers, or by-
standers who may not be immediately available once
the patient arrives in the ED.17 After initial patient
stabilization, a focused examination should evalu-
ate for common presenting signs of stroke.18 Pre-
hospital stroke assessment tools such as the Cincin-
nati Pre-hospital Stroke Scale and the Los Angeles
Pre-hospital Stroke Screen effectively identify stroke
patients in the field.21,22 These instruments have
demonstrated sensitivities of greater than 90%21,22
and should be used for the assessment of all patients
considered to be having a stroke.23
EMS management
Once initial stabilization has occurred, the Ameri-
can Stroke Association (ASA) guidelines for EMS
management of stroke patients state that trans-
port to the closest institution that provides emer-
gency stroke care should occur without delay.18 En
route, emergency medical personnel should manage
airways, breathing and circulation, initiate cardiac
monitoring and electrocardiogram (EKG), establish
intravenous (i.v.) access, provide oxygen to maintain
a saturation greater than 92%, perform a glucose
measurement, and keep the patient NPO (nothing
by mouth).18 The avoidance of supplemental oxygen
in nonhypoxic patients has been suggested by previ-
ous clinical trials of hospital patients, although the
use of supplemental oxygen for pre-hospital stroke
patients has not been evaluated in large-scale clini-
cal trials.24,25 The development of stroke protocols
for EMS personnel is strongly encouraged to con-
sistently and aggressively treat these patients.
Hospital notification
Advanced notification to the treating facility of an
incoming stroke patient by EMS has been shown to
be very beneficial in providing necessary prepara-
tion time to hospital personnel.26 Early notification
can be used to optimize downstream processes by
alerting stroke teams, reserving CT scanners, notify-
ing radiology personnel of impending stat head CT
imaging requiring interpretation, making pharma-
cists aware of the potential need for thrombolytics,
and improving chances for rapid evaluation of the
patient even during times of high ED volume and
occupancy.18,27 Pre-hospital notification by EMS as
compared to no notification was positively associ-
ated with neuroimaging completed within 25 min of
arrival and interpretation within 45 min of arrival,
which are in line with American Heart Association
(AHA) guidelines.11 This early notification has been
found to increase the percentage of patients with
acute stroke who receive thrombolytic therapy.11,28
Pre-hospital notification also leads to decreased de-
lays from ED arrival to neurological assessment
and initial brain imaging in patients brought in by
EMS.17 Communication between paramedics and
hospitals is paramount, and while it is routine for
paramedics to be in contact with receiving facilities
while en route, regardless of the patient condition, it
is crucial that hospitals have systems in place to max-
imize the use of this information when it is received,
similar to successes observed with the pre-hospital
activation of cardiac catheterization labs. A move-
ment from pre-hospital notification of the arrival of
stroke patients to pre-hospital activation of stroke
teams is likely to be of the highest yield.
Destination hospital
It is recommended that EMS providers rapidly
deliver stroke patients to primary stroke centers
(PSCs). Several studies have documented improved
patient outcomes when stroke patients are admit-
ted to a stroke unit or receive specialized stroke
care.23 Regional policies facilitating the transport
of patients to a PSC have demonstrated increased
thrombolytic use in appropriate patient popu-
lations.29−31 Regional stroke systems should be
used that implement policies and regulations to
ensure that stroke patients are transported to a PSC
regardless of the patient’s location.32 The patient
should be transported to the nearest PSC if it is
located within a reasonable transport distance and
transport time.32
Air medical transport
In some instances, stroke patients are in remote ge-
ographical locations with no local hospital facilities
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making it difficult for ground-based EMS systems
to deliver them to stroke centers in a timely fashion.
In these cases, use of air medical transport should be
considered.33 Given the current FDA-approved 3-h
time window for thrombolytic therapy, if ground
transportation is likely to take more than an hour,
it will likely preclude the ability to administer i.v.
rt-PA.17 In these cases, protocols should be in place
to transport these patients to stroke centers by air
ambulance if this will allow treatment within the
time horizon. The use of air medical transport could
potentially reduce transport time, increase availabil-
ity of thrombolytic therapy to those living in rural
communities, and be cost effective.33–36
Pre-hospital delivery of stroke treatment
With advancing science, there is interest in the de-
velopment of neuroprotective therapies that may be
used in the early treatment of acute ischemic stroke.
Much of the research using these agents has been
hindered by delayed time-to-delivery after the on-
set of stroke symptoms. There is a natural interest
in researching whether these agents can be success-
fully deployed in the pre-hospital phase. This may be
beneficial when transport times are long due to lack
of nearby medical centers and particularly in rural
regions. If patients could be accurately identified
as having a stroke by EMS personnel, paramedics
could be trained to deliver these agents in the back
of an ambulance during transport. This would be far
more efficient than waiting until the patient reaches
the medical center and is evaluated. In the Field Ad-
ministration of Stroke Therapy–Magnesium (FAST-
MAG) pilot trial, the research group studied the
safety and feasibility of paramedic initiation of in-
travenous magnesium sulfate in the field.37 They de-
termined that using tools to rate neurologic deficits,
such as the National Institutes of Health Stroke Scale
(NIHSS), was overly time-consuming and unwieldy
to deploy in the pre-hospital setting.37 Instead, they
used the Los Angeles Motor Scale (LAMS), which
rates severity of face, arm, and leg weakness on a
zero- to five-point scale.38 It is derived directly from
the Los Angeles Pre-hospital Stroke Screen (LAPSS)
and does not require additional evaluation time to
use, as the paramedics would have already adminis-
tered this tool at the start of their patient evaluation.
The LAMS was found to have excellent concur-
rent validity compared with the NIHSS, excellent
interrater reliability, and good long-tem outcome
predictive validity.37 The results of this study
demonstrated that enrollment in the trial and im-
plementation procedures did not increase the EMS
scene to ED transport times. They further found
that the initiation of magnesium sulfate in the field
is safe, feasible, and permits hyperacute delivery of
neuroprotective therapy.37 A phase III trial of pre-
hospital magnesium for stroke patients with definite
motor deficits is ongoing in southern California.
Access to stroke care
Stroke care in the United States can be highly vari-
able based on geographical location. In 2002, ap-
proximately 21% of U.S. counties did not have a
hospital, 31% lacked a hospital with an ED, and
77% had a hospital lacking neurological services.1A
recently published study found that 62% of U.S.
hospitals did not report treating any patients with
t-PA during the two-year study period.39 This lack of
nearby emergency neurological services in times of
acute stroke showcases the need for well-established
stroke systems of care that are often regional or even
state wide. EMS response and transportation pro-
tocols must be established and in place for survival
of these patients in critical neurologic situations.
These systems often mirror those in place for other
time-sensitive disease processes such as trauma and
acute myocardial infarction.
Stroke systems
As stroke is a time-sensitive disease process and the
window for intervention is very restrictive, the de-
velopment of stroke systems of care is paramount.
These concepts engulf more than single hospitals
and should be developed as regional or statewide
systems. The availability of resources to care for
acute stroke patients varies widely both among and
within communities.18 The resources, personnel in-
volved, infrastructure, and training required for op-
timizing these systems are substantial and require
advance planning, and frequent updating. EMS
medical directors, community leaders, physicians,
and hospital administrators should be active partic-
ipants, if not leaders, in the development of these
stroke systems.18,23 These stroke systems must ad-
dress issues related to communication, transporta-
tion, access to care, transfer of patients, sharing
of resources across EMS systems, and provide sys-
tematic review and evaluation.32 To be successful,
these stroke systems should use protocols, tools, and
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training that meet current AHA/ASA guidelines for
stroke care.32 Seamless teamwork between the EMS
and ED staff is one of the key issues in forming a
successful chain of recovery for acute stroke.12
Conclusion
Stroke is a substantial public health concern with
profound mortality and devastating morbidity.
Thrombolytic therapy is the sole approved treat-
ment for acute ischemic stroke; however, treatment
must be initiated within a narrow window. In 2009,
only 3.4–5.2% of patients with acute ischemic stroke
were treated with rt-PA.40 Delayed presentation to
the hospital is the primary reason patients are not
receiving thrombolytic treatment. Once patients ar-
rive in the ER, the testing and interpretation re-
quired to safely and appropriately administer t-PA
takes valuable time in an already very narrow win-
dow. Activation of an EMS system optimized to
promptly and accurately evaluate stroke patients
and deliver them to the nearest stroke center with
early notification to the accepting facility will im-
prove outcomes in stroke. Unfortunately, the gen-
eral public has limited understanding of signs and
symptoms associated with stroke, placing the bur-
den of suspecting stroke on EMS personnel. In order
for pre-hospital care to be successful, there needs to
be a well-established regional system for stroke care
with thorough training to ensure AHA/ASA guide-
lines for stroke care are met. There may also be a
future role for paramedics to provide neuroprotec-
tive agents to patients during transport to the stroke
center. EMS personnel have an important role in
the management of the acute stroke patient. De-
cisions made by dispatchers and paramedics can
affect the treatment and contribute to the outcome
of stroke patients. Seamless cooperation between
pre-hospital providers and ED staff will lead to im-
provements in the care of stroke patients.
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